Titan Pharmaceuticals Inc (TTNP)
3.92
-0.11
(-2.73%)
USD |
NASDAQ |
Nov 05, 16:00
3.92
0.00 (0.00%)
After-Hours: 16:24
Titan Pharmaceuticals Enterprise Value: -0.4068M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | -0.4068M |
| November 01, 2024 | -0.4297M |
| October 31, 2024 | -0.4433M |
| October 30, 2024 | -0.3885M |
| October 29, 2024 | -0.4799M |
| October 28, 2024 | -0.5988M |
| October 25, 2024 | -0.5677M |
| October 24, 2024 | -0.4692M |
| October 23, 2024 | -0.1599M |
| October 22, 2024 | -0.1325M |
| October 21, 2024 | 0.096M |
| October 18, 2024 | 0.288M |
| October 17, 2024 | 0.2515M |
| October 16, 2024 | 0.3337M |
| October 15, 2024 | 0.2057M |
| October 14, 2024 | 0.367M |
| October 11, 2024 | 0.4617M |
| October 10, 2024 | 0.3886M |
| October 09, 2024 | 0.48M |
| October 08, 2024 | 0.5714M |
| October 07, 2024 | 0.5074M |
| October 04, 2024 | 0.7543M |
| October 03, 2024 | 0.7771M |
| October 02, 2024 | 0.6995M |
| October 01, 2024 | 0.6674M |
| Date | Value |
|---|---|
| September 30, 2024 | 0.7268M |
| September 27, 2024 | 0.9188M |
| September 26, 2024 | 0.7177M |
| September 25, 2024 | 0.6537M |
| September 24, 2024 | 0.5257M |
| September 23, 2024 | 0.7405M |
| September 20, 2024 | 1.083M |
| September 19, 2024 | 0.992M |
| September 18, 2024 | 1.083M |
| September 17, 2024 | 1.257M |
| September 16, 2024 | 1.184M |
| September 13, 2024 | 0.9737M |
| September 12, 2024 | 0.9645M |
| September 11, 2024 | 1.056M |
| September 10, 2024 | 1.061M |
| September 09, 2024 | 1.175M |
| September 06, 2024 | 1.147M |
| September 05, 2024 | 1.312M |
| September 04, 2024 | 1.312M |
| September 03, 2024 | 1.138M |
| August 30, 2024 | 1.513M |
| August 29, 2024 | 1.087M |
| August 28, 2024 | 1.522M |
| August 27, 2024 | 2.062M |
| August 26, 2024 | 1.760M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-3.708M
Minimum
Dec 21 2023
41.28M
Maximum
Nov 20 2020
10.58M
Average
10.28M
Median
May 03 2023
Enterprise Value Benchmarks
| AIM ImmunoTech Inc | 8.843M |
| Perspective Therapeutics Inc | 530.78M |
| Protalix BioTherapeutics Inc | 69.53M |
| Electromed Inc | 180.63M |
| Armata Pharmaceuticals Inc | 170.01M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.093M |
| Total Expenses (Quarterly) | 2.074M |
| EPS Diluted (Quarterly) | -2.29 |
| Earnings Yield | -166.8% |
| Normalized Earnings Yield | -289.03 |